| Cmax | concentration at tmax |
| ECOG | Eastern Cooperative Oncology Group |
| GI | gastrointestinal |
| HR | hazard ratio |
| mCAP | metronomic capecitabine |
| OS | overall survival |
| PFS | progression free survival |
| PPIs | proton pump inhibitors |
| SD | standard deviation |
| RR | relative risk |
| Cmax | concentration at tmax |
| ECOG | Eastern Cooperative Oncology Group |
| GI | gastrointestinal |
| HR | hazard ratio |
| mCAP | metronomic capecitabine |
| OS | overall survival |
| PFS | progression free survival |
| PPIs | proton pump inhibitors |
| SD | standard deviation |
| RR | relative risk |